(VIANEWS) – GUERBET (GBT.PA), COFACE (COFA.PA), SBM OFFSHORE (SBMO.AS) are the highest payout ratio stocks on this list.
Here’s the data we’ve collected of stocks with a high payout ratio as yet. The payout ratio in itself isn’t a promise of a future good investment but it’s an indicator of whether dividends are being paid and how the company chooses to distribute them.
When investigating a potential investment, the dividend payout ratio is a good statistic to know so here is a list of some companies with an above 30% payout ratio.
1. GUERBET (GBT.PA)
85.86% Payout Ratio
Guerbet SA engages in the development and marketing of contrast media products, delivery systems, medical devices, and related solutions. The company offers Optiray and Xenetix, which are non-ionic monomeric and iodinated contrast agents; Telebrix Gastro, a meglumine ioxitalamate solution; Conray, an iothalamate meglumine injection; Micropaque/Microtrast, a diagnostic imaging interconnected solution; Dotarem, a gadoteric acid-gadoterate meglumine, and Artirem, a gadoteric acid that acts as a contrast agent for MRI, as well as prefilled syringes, injectors, accessories, and consumables for MRI, CT, and Cath Lab. It also provides digital solutions, such as Contrast&Care, an injection management solution; Dose&Care, an X-ray dose management solution; and icobrain, a cloud-based AI solution to quantify disease-specific brain structures for acute and chronic neurological conditions on MR and CT, as well as OptiProtect services. In addition, the company provides products for interventional radiology, including Lipiodol ethyl esters of iodinated fatty acids of poppyseed oil; Vectorio, a mixing and injection system for conventional trans-arterial chemoembolization; Patent Blue V, a blue dye; Axessio, a peripheral micro guidewire; and SeQure and DraKon, which are microcatheters. Further, it offers Hydra Vision, a digital imaging system for urological, gastroenterological, and gynecological treatment, as well as planning and diagnostic procedures; and urology accessories and consumables. The company was incorporated in 1926 and is headquartered in Villepinte, France.
Earnings Per Share
As for profitability, GUERBET has a trailing twelve months EPS of €-3.35.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -10.79%.
Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on Jun 29, 2023, the estimated forward annual dividend rate is 0.5 and the estimated forward annual dividend yield is 2.97%.
Moving Average
GUERBET’s value is below its 50-day moving average of €18.76 and below its 200-day moving average of €18.37.
Revenue Growth
Year-on-year quarterly revenue growth grew by 1.5%, now sitting on 775.1M for the twelve trailing months.
Volume
Today’s last reported volume for GUERBET is 30797 which is 237.46% above its average volume of 9126.
More news about GUERBET.
2. COFACE (COFA.PA)
79.17% Payout Ratio
COFACE SA, through its subsidiaries, provides credit insurance products and related services for microenterprises, small and medium enterprises, mid-market companies, international corporations, financial institutions, and clients of distribution partners. The company offers credit insurance products to protect companies against default on payment of its trade receivables. It also provides integrated credit management solutions comprising credit insurance, single risk insurance, business information and debt collection services for insured and uninsured businesses; and factoring services, as well as contract and environmental surety, customs and excise, and legal bonds; and payment guarantees. In addition, the company offers business information services through its ICON portal, an information services web platform. It operates in Western Europe, Northern Europe, Central and Eastern Europe, the Mediterranean and Africa, North America, Latin America, and the Asia-Pacific. COFACE SA was founded in 1946 and is headquartered in Bois-Colombes, France.
Earnings Per Share
As for profitability, COFACE has a trailing twelve months EPS of €1.92.
PE Ratio
COFACE has a trailing twelve months price to earnings ratio of 6.44. Meaning, the purchaser of the share is investing €6.44 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 14.56%.
Moving Average
COFACE’s worth is higher than its 50-day moving average of €11.44 and below its 200-day moving average of €12.53.
Revenue Growth
Year-on-year quarterly revenue growth declined by 4.4%, now sitting on 1.93B for the twelve trailing months.
Yearly Top and Bottom Value
COFACE’s stock is valued at €12.37 at 21:10 EST, way under its 52-week high of €14.44 and way above its 52-week low of €10.89.
More news about COFACE.
3. SBM OFFSHORE (SBMO.AS)
60.55% Payout Ratio
SBM Offshore N.V. provides floating production solutions to the offshore energy industry worldwide. The company operates in two segments, Lease and Operate, and Turnkey. It engages in the design, supply, installation, operation, lease, and life extension of floating production storage and offloading (FPSO) vessels, as well as semi-submersibles, tension leg platforms, liquefied natural gas (LNG) FPSOs, turret mooring systems, floating offshore wind, and brownfield and offshore loading terminals. The company also provides catenary anchor leg mooring (CALM) or single point mooring (SPM) terminal; as well as provides solutions for floating unit mooring, flexible flowline, and subsea structure installation works. As of December 31, 2022, it operated a fleet of 15 FPSOs and 1 semi-submersible unit. The company was formerly known as IHC Caland and changed its name to SBM Offshore N.V. in 2005. SBM Offshore N.V. was founded in 1862 and is headquartered in Schiphol, the Netherlands.
Earnings Per Share
As for profitability, SBM OFFSHORE has a trailing twelve months EPS of €1.67.
PE Ratio
SBM OFFSHORE has a trailing twelve months price to earnings ratio of 7.45. Meaning, the purchaser of the share is investing €7.45 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.82%.
Volume
Today’s last reported volume for SBM OFFSHORE is 151028 which is 68.38% below its average volume of 477641.
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on Apr 17, 2023, the estimated forward annual dividend rate is 1 and the estimated forward annual dividend yield is 8.31%.
More news about SBM OFFSHORE.
4. LECTRA (LSS.PA)
52.75% Payout Ratio
Lectra SA provides industrial intelligence solutions for fashion, automotive, and furniture markets. The company's solutions include software, automated cutting equipment, data, and related services, which enable customers to automate and optimize product design, development, and manufacture of garments, car seats and interiors, airbags, and sofas, as well as to digitalize their processes. It also offers technical maintenance, support, training, and consulting services; and sells consumables and parts. The company operates in Europe, the Americas, the Asia-Pacific, and internationally. Lectra SA was incorporated in 1973 and is headquartered in Paris, France.
Earnings Per Share
As for profitability, LECTRA has a trailing twelve months EPS of €0.91.
PE Ratio
LECTRA has a trailing twelve months price to earnings ratio of 32.14. Meaning, the purchaser of the share is investing €32.14 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.4%.
Sales Growth
LECTRA’s sales growth is 0.3% for the ongoing quarter and 2.2% for the next.
More news about LECTRA.
5. PERNOD RICARD (RI.PA)
52.47% Payout Ratio
Pernod Ricard SA produces and sells wines and spirits worldwide. The company offers whiskey, vodka, gin, rum, liqueur and bitters, champagne, tequila and mezcal, and aperitif under the brands 100 Pipers, Aberlour, Absolut, Absolut Elyx, Altos, ARARAT, Augier, Avion, Ballantine's, Becherovka, Beefeater, Blenders Pride, Brancott Estate, Campo Viejo, Ceder's, Chivas, Church Road, Clan Campbell, Del Maguey, George Wyndham, Green Spot, Havana Club, Imperial, Imperial Blue, Italicus, J.P. Wiser's, Jacob's Creek, Jameson, Jefferson's, Kahlúa, Kenwood, KI NO BI, Lillet, Long John, L'Orbe, Lot No. 40, Malfy, Malibu, Martell, Method & Madness, Midleton Very Rare, Minttu, Monkey 47, Mumm, Olmeca, Ostoya, Passport Scotch, Pastis 51, Pernod, Perrier-Jouët, Plymouth Gin, Powers, Rabbit Hole, Ramazzotti, Redbreast, Ricard, Royal Salute, Royal Stag, Scapa, Seagram's Gin, Secret Speyside, Smooth Ambler, Something Special, St Hugo, Stoneleigh, Suze, The Glenlivet, TX, Wyborowa, and Ysios. It also provides non-alcoholic beverages under the brands Ceder's, Suze Tonic 0%, Cinzano Spritz 0%, Pacific, Campo Viejo Sparkling 0%, and Jacob's Creek Unvined. Pernod Ricard SA was founded in 1805 and is headquartered in Paris, France.
Earnings Per Share
As for profitability, PERNOD RICARD has a trailing twelve months EPS of €8.81.
PE Ratio
PERNOD RICARD has a trailing twelve months price to earnings ratio of 17.2. Meaning, the purchaser of the share is investing €17.2 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 13.85%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 5.9%, now sitting on 12.14B for the twelve trailing months.
Sales Growth
PERNOD RICARD’s sales growth is 7.9% for the ongoing quarter and 7.9% for the next.
Moving Average
PERNOD RICARD’s worth is under its 50-day moving average of €162.95 and way below its 200-day moving average of €186.22.
More news about PERNOD RICARD.
6. BOIRON (BOI.PA)
40.15% Payout Ratio
Boiron SA manufactures and sells homeopathic medicines in France, rest of Europe, North America, and internationally. The company offers non-proprietary homeopathic medicines and homeopathic specialties; and other healthcare products include medical devices, invitro diagnostics, dietary supplements, cosmetics, and phytotherapy. It also provides homeopathic specialties comprising Oscillococcinum to treat influenza symptoms, such as fever, chills, headaches, and aches; Stodal and Stodaline for treating coughs; Arnigel for adjunctive local treatment of benign trauma in the absence of open wounds; Camilia for the treatment of teething problems for babies; Sédatif PC to treat anxiety and emotional, and minor sleep disorders; Coryzalia for the treatment of cold symptoms and rhinitis; Homéoptic to treat eye discomfort and irritation due to various causes for adults and children; Homéovox for vocal disorders; Homéoplasmine for treating irritated skin and redness; Varésol to treat symptoms of chickenpox; and Arnicare Arthritis for use in the treatment of benign trauma pain. In addition, it offers Dermoplasmine, a plant based multi-use balm that repairs and protects irritated and damaged skin; COVID self-tests and rapid antigenic tests; LABIAMEO, that used to treat outbreaks of localized cold sores; and CONVAMEO to treat physical and mental asthenia. The company offers its products through distribution centers, pharmacies, pharmacy chains, wholesalers, grocery and drugstores, health food stores, and online retail. Boiron SA was founded in 1932 and is headquartered in Messimy, France.
Earnings Per Share
As for profitability, BOIRON has a trailing twelve months EPS of €2.74.
PE Ratio
BOIRON has a trailing twelve months price to earnings ratio of 15.33. Meaning, the purchaser of the share is investing €15.33 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.64%.
Yearly Top and Bottom Value
BOIRON’s stock is valued at €42.00 at 21:10 EST, way below its 52-week high of €56.50 and way higher than its 52-week low of €37.00.
More news about BOIRON.
1. 1 (1)
1% Payout Ratio
1
Earnings Per Share
As for profitability, 1 has a trailing twelve months EPS of €1.
PE Ratio
1 has a trailing twelve months price to earnings ratio of 1. Meaning, the purchaser of the share is investing €1 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 1%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 1%, now sitting on 1 for the twelve trailing months.
Dividend Yield
According to Morningstar, Inc., the next dividend payment is on Jan 1, 1970, the estimated forward annual dividend rate is 1 and the estimated forward annual dividend yield is 1%.
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is 1% and 1%, respectively.
Volatility
1’s last week, last month’s, and last quarter’s current intraday variation average was 1.00%, 1.00%, and 1.00%.
1’s highest amplitude of average volatility was 1.00% (last week), 1.00% (last month), and 1.00% (last quarter).
More news about 1.
